Rigel Pharmaceuticals RIGL Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's interest paid?
- Rigel Pharmaceuticals (RIGL) reported interest paid of $1.32M in Q1 2026.
- How has Rigel Pharmaceuticals's interest paid changed year-over-year?
- Rigel Pharmaceuticals's interest paid decreased by 20.1% year-over-year, from $1.65M to $1.32M.
- What is the long-term trend for Rigel Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's interest paid has grown at a 44.7% compound annual growth rate (CAGR), from $1.5M to $6.57M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.